Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)

Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)

Abstract Introduction Patients with rheumatoid arthritis (RA) with poor prognostic factors, such as seropositivity for anti-citrullinated protein antibodies and early erosions, may benefit from early intensive treatment. However, information to guide physicians on the best choice of therapy in these...

Full description

Bibliographic Details
Main Authors: Roy Fleischmann, Michael Weinblatt, Harris Ahmad, Michael A. Maldonado, Evo Alemao, June Ye, Michael Schiff
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-10-01
Series:Rheumatology and Therapy
Subjects:
Disease activity
DMARDs (biologic)
Early rheumatoid arthritis
Rheumatoid arthritis
Online Access:http://link.springer.com/article/10.1007/s40744-019-00174-7

Internet

http://link.springer.com/article/10.1007/s40744-019-00174-7

Similar Items